128 related articles for article (PubMed ID: 18429604)
1. A targeted transport of 125I-labeled monoclonal antibodies to target proteins in experimental glioma focus.
Chekhonin VP; Baklaushev VP; Yusubalieva GM; Gurina OI; Dmitrieva TB
Dokl Biochem Biophys; 2008; 418():40-3. PubMed ID: 18429604
[No Abstract] [Full Text] [Related]
2. Targeted transport of 125I-labeled antibody to GFAP and AMVB1 in an experimental rat model of C6 glioma.
Chekhonin VP; Baklaushev VP; Yusubalieva GM; Gurina OI
J Neuroimmune Pharmacol; 2009 Mar; 4(1):28-34. PubMed ID: 18770045
[TBL] [Abstract][Full Text] [Related]
3. [Biodegradation of 125I-labeled monoclonal antibodies after introvenous administration to rats with experimental C6 glioma].
Chekhonina VP; Bulanov KA; Iusubalieva GM; Tsibul'kina EA; Gurina OI; Skoblov IuA; Shvets VI; Zhirkv IuA; Baklaushev VP
Biomed Khim; 2007; 53(5):532-40. PubMed ID: 18078067
[TBL] [Abstract][Full Text] [Related]
4. Expression of tenascin in human gliomas: its relation to histological malignancy, tumor dedifferentiation and angiogenesis.
Higuchi M; Ohnishi T; Arita N; Hiraga S; Hayakawa T
Acta Neuropathol; 1993; 85(5):481-7. PubMed ID: 7684178
[TBL] [Abstract][Full Text] [Related]
5. Human glioma associated intermediate filament proteins: over-expression, co-localization and cross-reactivity.
Abaza MS; Shaban F; Narayan RK; Atassi MZ
Anticancer Res; 1998; 18(2B):1333-40. PubMed ID: 9615812
[TBL] [Abstract][Full Text] [Related]
6. Modeling and immunohistochemical analysis of C6 glioma in vivo.
Chekhonin VP; Baklaushev VP; Yusubalieva GM; Pavlov KA; Ukhova OV; Gurina OI
Bull Exp Biol Med; 2007 Apr; 143(4):501-9. PubMed ID: 18214311
[TBL] [Abstract][Full Text] [Related]
7. Quantitative immunohistochemistry in the rat facial nucleus with [125I]-iodinated secondary antibodies and in situ autoradiography: non-linear binding characteristics of primary monoclonal and polyclonal antibodies.
Raivich G; Gehrmańn J; Graeber MB; Kreutzberg GW
J Histochem Cytochem; 1993 Apr; 41(4):579-92. PubMed ID: 8450197
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical studies on cellular character of microtumors induced by ethylnitrosourea in the rat brain utilizing anti-Leu 7 and anti-glial fibrillary acidic protein antibodies.
Yoshino T; Motoi M; Ogawa K
Acta Neuropathol; 1985; 66(2):167-9. PubMed ID: 2990142
[TBL] [Abstract][Full Text] [Related]
9. Targeted delivery of liposomal nanocontainers to the peritumoral zone of glioma by means of monoclonal antibodies against GFAP and the extracellular loop of Cx43.
Chekhonin VP; Baklaushev VP; Yusubalieva GM; Belorusova AE; Gulyaev MV; Tsitrin EB; Grinenko NF; Gurina OI; Pirogov YA
Nanomedicine; 2012 Jan; 8(1):63-70. PubMed ID: 21703991
[TBL] [Abstract][Full Text] [Related]
10. Specific monoclonal antibodies to glial fibrillary acidic protein (GFAP).
Courel MN; Girard N; Delpech B; Chauzy C
J Neuroimmunol; 1986 Jun; 11(4):271-6. PubMed ID: 3711313
[TBL] [Abstract][Full Text] [Related]
11. [Antibodies to glial fibrillary antigen as potential carriers of drugs for glial tumors].
Obukhov SK; Kalashnikova VV; Khalanskiĭ AS
Zh Vopr Neirokhir Im N N Burdenko; 1989; (2):30-2. PubMed ID: 2787569
[TBL] [Abstract][Full Text] [Related]
12. The upregulation of a glial cell surface antigen at the astrocytic scar in the rat.
Irwin MH; Geisert EE
Neurosci Lett; 1993 May; 154(1-2):57-60. PubMed ID: 8361649
[TBL] [Abstract][Full Text] [Related]
13. Laminin expression by glial fibrillary acidic protein positive cells in human gliomas.
Tysnes BB; Mahesparan R; Thorsen F; Haugland HK; Porwol T; Enger PO; Lund-Johansen M; Bjerkvig R
Int J Dev Neurosci; 1999; 17(5-6):531-9. PubMed ID: 10571414
[TBL] [Abstract][Full Text] [Related]
14. Visualization of Connexin 43-positive cells of glioma and the periglioma zone by means of intravenously injected monoclonal antibodies.
Baklaushev VP; Yusubalieva GM; Tsitrin EB; Gurina OI; Grinenko NP; Victorov IV; Chekhonin VP
Drug Deliv; 2011 Jul; 18(5):331-7. PubMed ID: 21309693
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies reactive with epitopes restricted to glial fibrillary acidic proteins of several species.
Pegram CN; Eng LF; Wikstrand CJ; McComb RD; Lee YL; Bigner DD
Neurochem Pathol; 1985; 3(2):119-38. PubMed ID: 2413405
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies to 125 kd and 95 kd proteins on human melanoma cells: comparison with other monoclonal-defined melanoma antigens.
Saxton RE; Mann BD; Morton DL; Burk MW
Hybridoma; 1982; 1(4):433-45. PubMed ID: 6208138
[TBL] [Abstract][Full Text] [Related]
17. Expression of vimentin and glial fibrillary acidic protein in ethylnitrosourea-induced rat gliomas and glioma cell lines.
Reifenberger G; Bilzer T; Seitz RJ; Wechsler W
Acta Neuropathol; 1989; 78(3):270-82. PubMed ID: 2475009
[TBL] [Abstract][Full Text] [Related]
18. The biology of malignant gliomas--a comprehensive survey.
McComb RD; Bigner DD
Clin Neuropathol; 1984; 3(3):93-106. PubMed ID: 6205806
[TBL] [Abstract][Full Text] [Related]
19. Applications of monoclonal antibodies in the diagnosis and treatment of primary brain tumors.
Bullard DE; Bigner DD
J Neurosurg; 1985 Jul; 63(1):2-16. PubMed ID: 2409248
[TBL] [Abstract][Full Text] [Related]
20. Treatment of intracranial human glioma xenografts with 131I-labeled anti-tenascin monoclonal antibody 81C6.
Lee Y; Bullard DE; Humphrey PA; Colapinto EV; Friedman HS; Zalutsky MR; Coleman RE; Bigner DD
Cancer Res; 1988 May; 48(10):2904-10. PubMed ID: 2452014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
